Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

U.S. government stockpile of COVID-19 vaccines already drained

By Brian Buntz | January 15, 2021

Pfizer-BioNTech vaccine

Pfizer-BioNTech vaccine image courtesy of Wikipedia

Last week, President-elect Joe Biden vowed to release COVID-19 vaccine doses from a government stockpile. 

On Jan. 13, the U.S. Department of Health and Human Services (HHS) echoed that sentiment, stating it would “no longer stockpile millions of COVID-19 vaccine doses held to ensure Americans receive their second shot,” according to a brief notice. 

But federal officials had already drained vaccine reserves before the HHS vowed to open up a vaccine stockpile, according to state officials who had been expecting more doses.

Local government officials expecting vaccine supplies to roughly double starting next week are now forced to contend with the status quo. 

Critics of Operation Warp Speed, a public-private partnership established by the Trump administration to support COVID-19 vaccine distribution, have been frustrated with the speed at which they say the Trump administration has made vaccines available after the FDA authorized two for use. Oregon Gov. Kate Brown, for instance, referred to the recent news about the stockpile as “deception on a national scale.”

In late December, the Trump administration had shifted its policy to cease stockpiling doses of the Pfizer-BioNTech vaccine, according to the Washington Post.

HHS Secretary Alex Azar had previously argued that it would be potentially unethical to free up the stockpile, increasing the risk that recipients of the first COVID-19 dose would miss their second shot. 

In related news, Operation Warp Speed leaders reportedly waited more than two months to sign off on a proposal from the CDC to distribute COVID-19 vaccines, according to a report from the Wall Street Journal.  

In the waning days of the Trump administration, the U.S. government is attempting to accelerate vaccinations, loosening eligibility guidelines while states race to bolster their capacity to administer doses.

Tell Us What You Think! Cancel reply

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards